Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (in vitro human macrophage RNA-Seq)

ABSTRACT: Despite the pivotal role of tumor-associated macrophages (TAMs) in modulating anti-tumor immunity, the conserved patterns and molecular determinates for the formation of diverse TAM subsets remain largely elusive. In this study, we uncovered the exclusive distribution of pro-angiogenic and MHC-II programs of TAMs are well-conserved, and identified key genes and pathways required for macrophage polarization by tumor cells by CRISPR screen. Notably, we demonstrated that multiple TAM phenotypes were mainly shaped by the synergistic and antagonistic interactions between GM-CSF, PGE2, and lactic acid. We further found the inactivation of Adar, an RNA-editing enzyme, reprograms TAMs into an ISG+ phenotype characterized by the high expression of immune stimulatory genes, thereby enhancing the anti-tumor immune response. Thus, our study illuminates the molecular principles underlying the generation and rewiring of TAM functional phenotypes.

ORGANISM(S): Homo sapiens

PROVIDER: GSE301110 | GEO | 2025/08/03

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (in vivo ATAC-Seq)

Project description:Despite the pivotal role of tumor-associated macrophages (TAMs) in modulating anti-tumor immunity, the conserved patterns and molecular determinates for the formation of diverse TAM subsets remain largely elusive. In this study, we uncovered the exclusive distribution of pro-angiogenic and MHC-II programs of TAMs are well-conserved, and identified key genes and pathways required for macrophage polarization by tumor cells by CRISPR screen. Notably, we demonstrated that multiple TAM phenotypes were mainly shaped by the synergistic and antagonistic interactions between GM-CSF, PGE2, and lactic acid. We further found the inactivation of Adar, an RNA-editing enzyme, reprograms TAMs into an ISG+ phenotype characterized by the high expression of immune stimulatory genes, thereby enhancing the anti-tumor immune response. Thus, our study illuminates the molecular principles underlying the generation and rewiring of TAM functional phenotypes.

2025-08-03 | GSE269029 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages [RNA-Seq]

Project description:Despite the importance of tumor-associated macrophages (TAMs) in modulating anti-tumor immunity, the molecular determinants of their functional phenotypes remain elusive. Through a large-scale CRISPR screen, we discovered that tumor-derived lactic acid, PGE2, and GM-CSF collaboratively shape the highly conserved but mutually exclusive TAM phenotypes: MHC-II+ and angiogenic TAMs. Mechanistically, the dichotomous nature of these two phenotypes is driven by the antagonistic interactions between lactic acid/PGE2 and GM-CSF. Lactic acid and PGE2 coordinately induce the angiogenic gene program while suppressing the GM-CSF-induced MHC-II program at chromatin level. This mechanism leads to distinct spatial distribution of TAMs, with angiogenic TAMs in lactate-rich hypoxic regions and MHC-II+ TAMs outside these areas. Furthermore, in vivo genetic perturbation of TAMs showed that shifting TAMs to an interferon responsive program, triggered by Adar inactivation, substantially potentiates anti-tumor immunity. Our findings suggest a conserved mechanism of TAM polarization and a potential approach for reprogramming TAMs in immunotherapy.

2025-08-03 | GSE237783 | GEO

Complex interaction of tumor-derived factors instructs the spatially distinct phenotypes of tumor-associated macrophages [scRNA-Seq]

2025-08-03 | GSE237849 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (in vivo RNA-Seq)

2025-08-03 | GSE269030 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (in vitro RNA-Seq)

2025-08-03 | GSE269028 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (in vitro ATAC-Seq)

2025-08-03 | GSE269027 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages (CROP-Seq, in vivo LGP pool)

2025-08-03 | GSE269026 | GEO

Complex interaction of tumor-derived factors instructs the niche specific phenotypes of tumor-associated macrophages [CROP-Seq, in vitro and in vivo pool]

2025-08-03 | GSE237782 | GEO

High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors

Project description:Clinical and experimental evidence indicates that tumor-associated macrophages (TAMs) promote malignant progression. In breast cancer, TAMs enhance tumor angiogenesis, tumor cell invasion, matrix remodeling, and immune suppression against the tumor. In this study, we examined late-stage mammary tumors from a transgenic mouse model of breast cancer. We used flow cytometry under conditions that minimized gene expression changes to isolate a rigorously defined TAM population previously shown to be associated with invasive carcinoma cells. The gene expression signature of this population was compared with a similar population derived from spleens of non-tumor-bearing mice using high-density oligonucleotide arrays. Using stringent selection criteria, transcript abundance of 460 genes was shown to be differentially regulated between the two populations. Bioinformatic analyses of known functions of these genes indicated that formerly ascribed TAM functions, including suppression of immune activation and matrix remodeling, as well as multiple mediators of tumor angiogenesis, were elevated in TAMs. Further bioinformatic analyses confirmed that a pure and valid TAM gene expression signature in mouse tumors could be used to assess expression of TAMs in human breast cancer. The data derived from these more physiologically relevant autochthonous tumors compared with previous studies in tumor xenografts suggest tactics by which TAMs may regulate tumor angiogenesis and thus provide a basis for exploring other transcriptional mediators of TAM trophic functions within the tumor microenvironment. Tumor-associated macrophages from late-stage mouse mammary tumors compared to splenic macrophages from non-tumor-bearing littermate controls. 4 biological replicates of each population were compared via gene expression arrays.

2010-06-21 | E-GEOD-18404 | biostudies-arrayexpress

DICER controls macrophage polarization and tumor response to immunotherapy

Project description:Tumor-associated macrophages (TAMs) have immunosuppressive capacity in mouse models of cancer. Here we show that the genetic deletion of the microRNA (miRNA)-processing enzyme DICER in TAMs broadly programs them to a CD11c+MRC1â/low M1-like immunostimulatory phenotype characterized by activated interferon-Î³ (IFN-Î³)/STAT1/IRF signaling. M1-like TAM programming fostered the recruitment of cytotoxic T-cells (CTLs), including tumor-antigen-specific CTLs, inhibited tumor growth, and enhanced the efficacy of PD1 checkpoint blockade. Bioinformatics analysis of TAM transcriptomes identified a limited set of miRNAs putatively involved in TAM programming. Re-expression of Let-7 in Dicer-deficient TAMs was sufficient to partly rescue the M2-like (protumoral) TAM phenotype and abate tumor CTL infiltration. Targeted suppression of DICER activity in TAMs may, therefore, stimulate antitumor immunity and enhance the efficacy of cancer immunotherapy. To explore the role of DICER in the development, activation and immunological functions of TAMs, we crossed homozygous LysM-Cre (Clausen et al., 1999) with Dicerlox/lox (Harfe et al., 2005) mice to obtain mice with myeloid-cell-specific Dicer1 gene deletion (LysM-Cre;Dicerâ/â, referred to as Dâ/â). These mice were then backcrossed to LysM-Cre to obtain the control LysM-Cre; Dicer+/+ mice (referred to as D+/+). Both LysM-Cre and Dicerlox/lox mutations were always homozygous in our experiment. We then inoculated Lewis lung carcinoma (LLC) cells subcutaneously (s.c.) in Dâ/â and control D+/+ mice. Once the tumors were established, we isolated by fluorescence-activated cell sorting (FACS) tumor-associated macrophages (F4/80+ cells).

2016-06-13 | E-GEOD-76356 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data